Join us for the 17th Annual Crock Lecture, exploring how cutting-edge neuroscience is transforming glaucoma research and patient care.

About the lecture

Glaucoma is a progressive neurodegenerative disease that leads to the loss of retinal ganglion cells in the eye and irreversible vision impairment. Professor Pete Williams will present new research targeting NAD metabolism for neuroprotection. NAD is a coenzyme found in all living cells, which is essential for energy production. Pete’s research highlights how restoring energy levels in the eye can protect retinal cells and preserve vision.

He will discuss how this work, complemented by ongoing clinical trials and drug development, aims to enhance the resilience of neurons and support new treatments that go beyond just lowering pressure in the eye.

About Professor Pete Williams

Pete Williams will be joining CERA in January 2026 as a Research Lead, establishing the new Neuroprotection and Repair Unit. He joins us from the Karolinska Institutet, Sweden, where he was the Ulla and Ingemar Dahlberg Professor in Vision Science. His new research group at CERA explores how bioenergetic insufficiency drives neurodegeneration in conditions such as glaucoma and is developing new treatments based on these findings. He is a renowned neuroscientist with research spanning from the laboratory through to clinical trials, and was the first to show the neuroprotective potential of nicotinamide in glaucoma. This has now led to multiple clinical trials across the globe to validate nicotinamide as a potential new treatment for glaucoma.

BOOK YOUR IN-PERSON OR ONLINE TICKET

Event details

• Wednesday 11 March 2026
• 5.30pm – 7.30pm AEDT for in person (6.15pm – 7.30pm AEDT for the livestream)
• Martin Family Auditorium, Level 4, The Royal Victorian Eye and Ear Hospital, 32 Gisborne St, East Melbourne 3002

Registrations are essential. If you have trouble registering, please call CERA directly on 03 9959 0000.